| Line Item | 2024-12-31 | Y/Y |
|---|---|---|
| Revenue | $0 | — |
| R&D Expense | $10.5M | -40.2% |
| SG&A Expense | $10.6M | -20.9% |
| Operating Income | -$21.2M | +31.9% |
| Income Tax | $3K | — |
| Net Income | -$21.1M | +31.6% |
| EPS (Basic) | -$5.34 | +76.3% |
| Line Item | 2024-12-31 | Y/Y |
|---|---|---|
| Cash & Equivalents | $1.6M | -76.2% |
| Current Assets | $2.1M | -72.4% |
| Total Assets | $4.1M | -61.3% |
| Current Liabilities | $2.5M | -23.0% |
| Stockholders' Equity | $1.6M | -78.2% |
| Line Item | 2024-12-31 | Y/Y |
|---|---|---|
| Operating Cash Flow | -$17.1M | +30.7% |
| Investing Cash Flow | $1K | +101.6% |
| Financing Cash Flow | $12.0M | +13.4% |